Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Regulatory
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Morquio A disease (MPS IVA) results from a deficiency of the
N-acetylgalactosamine-6-sulfate sulfatase enzyme. This enzyme
hydrolyzes a sulfate group from the 6 position of galactose at the
nonreducing terminus of the mucopolysaccharides, keratin sulfate
and chondroitin-6 sulfate.
In this procedure, the tritiated disulfated trisaccharide,
(6-DGalNAc-6-SO[4]) 1-4(beta-DGlcU)1-3 (D-[3]H GalNac-ol-6-SO[4]), is
used as the substrate. The enzyme hydrolyzes the substrate to form
inorganic sulfate and the labeled monosulfated trisaccharide. The
monosulfated product is then separated from the disulfated substrate
by anion exchange chromatography. The product is then quantitated
by scintillation counting. (Glosse J, Kress H: A sensitive procedure
for the diagnosis of N-acetylgalatosamine-6-sulfate sulfatase
deficiency in classical Morquio's disease. Clin Chim Acta
1978;88:111-119)

